As a Swiss pharmaceutical manufacturer, Acino has a long history of producing oral solid dose products. We are a leader in advanced drug delivery systems with a focus on dispersible and complex modified release formulations such as Multi-Unit Pellet System (MUPS).
Every day, Acino strives to evolve its manufacturing capabilities, infrastructure and technology in order to offer best-in-class solutions to our customers as part of our ambition to be the preferred high-quality contract manufacturing and out-licensing partner, said Steve Mahoney.
Manufacturing sites: Switzerland (2), Ukraine, Estonia, United Arab Emirates and South Africa
Regional offices: Dubai, Kyiv, Johannesburg, Moscow and Panama City
Blisters in 2021
Aluminum foil used in 2021
Packs shipped in 2021
High tower of all packs shipped in 2021
Global registrations
Qualified suppliers in 2021
Weeks from RFQ to Offer
Transfer projects in 2021
Pharma customers
Batch release on time
Fill out the following form to get in touch with us and/or download our presentation now.
We would be delighted to meet with you at one of the following conferences.
22-23 March 2023, Amsterdam, Netherlands
Speaker: Yuliyana Manolova
Presentation: Navigating high inflation in pharmaceutical manufacturing
28-30 March 2023, Berlin, Germany
Speaker: Yuliyana Manolova
Presentation: Navigating high inflation in pharmaceutical manufacturing
12-13 June 2023, Geneva, Switzerland
Speaker: Yuliyana Manolova
Presentation: Navigating high inflation in pharmaceutical manufacturing
15-16 June 2023, Frankfurt, Germany
Speaker: Yuliyana Manolova
Presentation: Navigating high inflation in pharmaceutical manufacturing
27-30 September 2023, Düsseldorf, Germany
24-26 October 2023, Barcelona, Spain
